1 Lang PO, Dramé M. Le vieillissement démographique: comment mesurer la qualité de notre avenir? Neur Psychiatr Geriatr. 2013;13:256–66.
2 Lang PO, Proust J, Vogel T, Aspinall R. Saurons-nous jamais ce qui provoque le vieillissement? Neur Psychiatr geriatr. 2013;13:337–43.
3 Sauver JL, Boyd CM, Grossardt BR, Bobo WV, Finney Rutten LJ, Roger VL, et al. Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. BMJ Open. 2015;5:e006413.
4 Boland B, Guignard B, Dalleur O, Lang PO. Application of STOPP/START and Beers criteria: Compared analysis on identification and relevance of potentially inappropriate prescriptions.
Eur Geriatr Med. 2016;7:416–23.
5 Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716–24.
6 Payne RA, Avery AJ, Duerden M, Saunders CL, Simpson CR, Abel GA. Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharmacol. 2014;70:575–81.
7 Brulhart MI, Wermeille JP. Multidisciplinary medication review: Evaluation of a pharmaceutical care model for nursing homes.
Int J Clin Pharmacol. 2011;33:549–57.
8 Quinodoz A, Deruaz-Luyet A, N’Goran AA, Herzig L. Stratégie de priorisation dans la prise en charge des patients multimorbides en médecine de famille. Rev Med Suisse. 2016;12:928–31.
9 Riat F, Rochat S, Büla C, Renard D, Monod S. Principes d’évaluation et de prise en charge des patients âgés polymorbides: guide à l’intention des cliniciens. Rev Med Suisse. 2012;8:2109–14.
10 Lang PO, Dramé M, Jolly D, Novella JL, Blanchard F, Michel JP. Que nous apprend la cohorte SAFEs sur l’adaptation des filières de soins à la prise en charge des patients âgés. Presse Med. 2010;39:1132–42.
11 Bischoff T, Herzig L, Sommer J, Haller DM. Multimorbidité: une opportunité pour changer de regard. Rev Med Suisse. 2016;12:915.
12 Desnoyer A, Guignard B, Lang PO, Desmeules J, Vogt-Ferrier N, Bonnabry P. Prescriptions médicamenteuses potentiellement inappropriées en gériatrie: quels outils utiliser pour les détecter? Press Med. 2016;45:957–70.
13 Topinková E, Baeyens JP, Michel JP, Lang PO. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging. 2012;29:477–94.
14 Garcia-Caballos M, Ramos-Diaz F, Jimenez-Moleon JJ, Bueno-Cavanillas A. Drug-related problems in older people after hospital discharge and interventions to reduce them. Age Ageing. 2010;39:430–8.
15 O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29:437–52.
16 American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians.
J Am Geriatr Soc. 2012;60:1–25.
17 Reuben DB, Tinetti ME. Goal-oriented patient care – an alternative health outcomes paradigm. N Eng J Med. 2012;366:777–9.
18 Fried TR, McGraw S, Agostini JV, Tinetti MV. Views of Older Persons with Multiple Morbidities on Competing Outcomes and Clinical Decision-Making. J Am Geriatr Soc. 2008;56:1839–44.
19 Lang PO, Meyer N, Heitz D, Dramé M, Jovenin N, Ankri J, et al. Loss of independence in Katz’s ADL ability in connection with an acute hospitalization: early clinical markers in French older people.
Eur J Epidemiol. 2007;22:621–30.
20 Vaucher Y, Monod S, Büla C, Rochat S. Evaluation de l’espérance de vie chez les personnes âgées. Rev Med Suisse. 2012;8:2115–8.
21 Walter LC, Covinski KE. Cancer screening in elderly patients:
A framework for indivualized decision making. JAMA. 2001;285:2750–6.
22 Yourmann LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review.
JAMA. 2012;307:182–92.
23 Lordos EF, Herrmann FR, Robine JM, Balahoczky M, Giannelli SV, Gold G, Michel JP. Comparative value of medical diagnosis versus physical functioning in predicting the 6-year survival of 1951 hospitalized old patients. Rejuvenation Res. 2008;11:829–36.
24 Montori VM, Brito JP, Murad MH. The optimal practice of Evidence-Based Medicine. Incorporating patient preference in practice guidelines. JAMA. 2013;310:2503–4.
25 Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G, et al. The persistent exclusion of older subjects from ongoing clinical trials in heart failure. Arch Intern Med. 2011;171:550–6.
26 Mutasingwa DR, Ge H, Upshur RE. How applicable are clinical practice guidelines to elderly patients with comorbidities?
Can Fam Physician. 2011;57:253–62.
27 Lang PO, Aspinall R. Vaccination in the elderly: what can be recommended? Drugs Aging. 2014;31:581–99.
28 McElhaney JE, Gavazzi G, Flamaing J, Petermans J. The role of vaccination in successful independent ageingOriginal Research Article. Eur Geriatr Med. 2016;7:171–5.
29 Bouaziz W, Lang PO, Schmitt E, Kaltenbach G, Geny B, Vogel T. Health benefits of multicomponent training programmes in seniors: a systematic review. Int J Clin Pract. 2016;70:520–36.
30 Chang CB, Chan DC. Comparison of published explicit criteria for potentially inappropriate medications in older adults.
Drugs Aging. 2010;27:947–57.
31 Spinewine A SK, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173–84.
32 Lang PO, Boland B, Dalleur O. Prescription médicamenteuse inappropriée: les nouveaux critères STOPP/START. Rev Med Suisse. 2015;11:2115–23.
33 By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63:2227–46.
34 Wauters M, Elseviers M, Vaes B, Degryse J, Dalleur O, Vander Stichele R, Christiaens T, Azermai M. Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old.
Br J Clin Pharmacol. 2016;epub ahead of print.
35 O’Connor MN, O’Sullivan D, Gallagher PF, Eustace J, Byrne S, O’Mahony D. Prevention of hospital-acquired adverse drug reactions in older people using screening tool of older persons’ prescriptions and screening tool to alert to right treatment criteria: a cluster randomized controlled trial. J Am Geriatr Soc. 2016;64:1558–66.
36 Lang PO, Petrovic M, Dalleur O, Ferahta N, Benetos A, Boland B.
The exercise in applying STOPP/START.v2 in vulnerable very old patients: Towards patient tailored prescribing. Eur Geriatr Med. 2016;7:176–9.
37 Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris IS. Effectiveness of the STOPP/START Screening tool of older persons’ potentially inappropriate prescriptions/screening tool to alert doctors to the right treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016;41:158–69.
38 Takeda-Raguin C, Vogel T, Ferahta N, Smith C, Poloni B, Lang PO. Adherence to Long-Term Drug Regimen After Hospital Discharge: General Practitioners’ Attitude. J Am Geriatr Soc 2016;64:657–9.
39 O’Mahony D, Gallagher P, Ryan C, Byrne S, Hamilton H, Barry P, O’Connor M, Kennedy J. STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age.
Eur Geriatr Med 2010;1:45–51.
5 Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716–24.
12 Desnoyer A, Guignard B, Lang PO, Desmeules J, Vogt-Ferrier N, Bonnabry P. Prescriptions médicamenteuses potentiellement inappropriées en gériatrie : quels outils utiliser pour les détecter? Press Med. 2016;45:957–70.
16 American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians.
J Am Geriatr Soc 2012;60:1–25.
32 Lang PO, Boland B, Dalleur O. Prescription médicamenteuse inappropriée: les nouveaux critères STOPP/START.
Rev Med Suisse. 2015;11:2115–23.
36 Lang PO, Petrovic M, Dalleur O, Ferahta N, Benetos A, Boland B. The exercise in applying STOPP/START.v2 in vulnerable very old patients: Towards patient tailored prescribing. Eur Geriatr Med. 2016;7:176–9.